zircon: RN given refers to Zr(+4)[1:1] salt; structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| ID Source | ID |
|---|---|
| PubMed CID | 61775 |
| MeSH ID | M0044905 |
| Synonym |
|---|
| 14940-68-2 |
| hyacinth |
| zirconium silicate |
| 10101-52-7 |
| zirconium(iv) silicate, nanopowder, <100 nm particle size (bet), 98.5% trace metals basis |
| zirconium(iv) silicate, -325 mesh |
| einecs 239-019-6 |
| standard sf 200 |
| zircon |
| zirconite |
| silicic acid, zirconium(4+) salt (1:1) |
| zirconium(iv) silicate (1:1) |
| a-pax 45m |
| zircosil 15 |
| ultrox 500w |
| zircon (zr(sio4)) |
| FT-0695365 |
| einecs 233-252-7 |
| excelopax |
| einecs 215-690-0 |
| mz 1000b |
| silicic acid (h4sio4), zirconium(4+) salt (1:1) |
| zircosil 1 |
| micro-pax |
| silicic acid, zirconium(4+) salt |
| unii-4sy8h89134 |
| tam 418 |
| 4sy8h89134 , |
| zirconium orthosilicate |
| micro-pax sp |
| zirconium orthosilicate (zrsio4) |
| silicon zirconium oxide (sizro4) |
| oscal 1224 |
| silicic acid (h4sio4) zirconium(4+) salt (1:1) |
| zirconium silicon oxide (zrsio4) |
| zircosil |
| zircon 30my |
| micro-pax 20a |
| a-pax-sa |
| zirconium(iv) orthosilicate |
| zirconium silicon oxide |
| zircon flour 100 |
| silicic acid, zirconium salt (1:1) |
| zirconium silicate [inci] |
| zirconium silicate [mi] |
| silicon zirconium oxide (zrsio4) |
| zirconium silicate [who-dd] |
| AKOS025243327 |
| zirconium(iv) silicate |
| zirconium silicate, <2 micron powder |
| mfcd00085353 |
| 1344-21-4 |
| zirconium(4+);silicate |
| zirconium silicate nanopowder |
| Q2342917 |
| DTXSID60892246 |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 4 (3.36) | 18.7374 |
| 1990's | 16 (13.45) | 18.2507 |
| 2000's | 38 (31.93) | 29.6817 |
| 2010's | 50 (42.02) | 24.3611 |
| 2020's | 11 (9.24) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 6 (4.96%) | 5.53% |
| Reviews | 2 (1.65%) | 6.00% |
| Case Studies | 1 (0.83%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 112 (92.56%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||